Comprehensive guide to mdr-tb treatment. Expert-written information on symptoms, diagnosis, treatment options, and prevention strategies for better respiratory health.
Multidrug-Resistant TB (MDR-TB) does not respond to Isoniazid and Rifampicin. Treatment is longer and more complex but curable.
All information provided in this guide is reviewed by board-certified physicians and medical professionals at Chest Clinic of Kathmandu. We are committed to providing accurate, up-to-date medical information based on current clinical guidelines.
Yes, treatment success rates of 70-85% achievable.
From person with MDR-TB or inadequate treatment.
Medical information verified by specialists
Content reviewed for accuracy
Based on current medical guidelines
Our expert team at Chest Clinic of Kathmandu is here to provide personalized medical advice and treatment options.
Book Consultation